Revenue
2022
2023
2024
2025
Mosaic ImmunoEngineering Inc. (CPMV)
Price$0.0610Cached quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 · Dec 31 | 2020 · May 31 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $63,981 | $183,867 | $435,449 | $1.0M | $1.5M | $342,727 | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $616,119 | $879,655 | $1.4M | $2.6M | $3.5M | $835,632 | $996,019 | $734,062 | $1.0M | $1.2M | $1.6M | $1.4M | $1.7M | $1.4M | $2.0M | $2.6M |
| Operating income | −$616,119 | −$879,655 | −$1.4M | −$2.6M | −$3.5M | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$602,113 | −$837,650 | −$916,660 | −$2.2M | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$687,846 | −$921,983 | −$1.0M | −$2.4M | −$3.7M | −$842,243 | −$1.1M | −$798,463 | −$1.2M | −$45,368 | −$1.3M | −$1.5M | −$1.5M | $1.1M | −$4.8M | −$11.5M |
| Basic EPSper basic share | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | -$1.12 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.03 |
| Diluted EPSper diluted share | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | -$1.12 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.03 |
Owners
Reported shareholders